Phase Ib Study of Z-213 in Subjects With Iron-deficiency Anemia - To Investigate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics
Phase of Trial: Phase I
Latest Information Update: 01 May 2018
Price : $35 *
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Pharmacokinetics
- Sponsors Zeria
- 19 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.